CDSCO UID IMP/MD/2018/000187_fc76cd02a419071811882a0ea9765a24_778ed64c647b22141fa43a1f23d5df0dDirect Total Iron Binding Capacity Reagent
- UID
- IMP/MD/2018/000187_fc76cd02a419071811882a0ea9765a24_778ed64c647b22141fa43a1f23d5df0d
- Device class
- Class B
- Brand name
- Transferrin, C3, C4, IgA, IgG, IgM
- License holder
- M/s. Ortho Clinical Diagnostics India Private Limited
- Approving authority
- CDSCO
- Product information
- For in vitro diagnostic use only VITROS Chemistry Products dTIBC Reagent is used on the VITROS Chemistry System and the VITROS Integrated System to quantitatively measure total iron-binding capacity (Transferrin, C3, C4, IgA, IgG, IgM) in human serum. The iron-binding capacity is useful in the differential diagnosis of anemia, iron deficiency anemia, thalassemia, sideroblastic anemia, and iron poisoning
Direct Total Iron Binding Capacity Reagent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000187_fc76cd02a419071811882a0ea9765a24_778ed64c647b22141fa43a1f23d5df0d. This device is marketed under the brand name Transferrin, C3, C4, IgA, IgG, IgM. The license holder is M/s. Ortho Clinical Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.